Factors Affecting Wait Times in Living-Donor Kidney Transplant

Background: Living donor kidney transplant (LDKT) offers a life-saving option for patients with end stage kidney disease, reducing wait times compared to deceased donor transplants. However, the characteristics of candidates that wait a shorter period compared to those waiting longer is unclear. We stratified the cohort by duration of wait times for a LDKT to analyze characteristics. Methods: We included adult LDKT recipients at the University of Pennsylvania between 1/1/2015 and 11/30/2023. The wait time for a LDKT was defined as the time from the date of waitlisting to time of transplant. Patient characteristics were analyzed based on wait times of <1 year, 1-2 years, and >2 years. Pertinent factors determining wait times for a well-matched LDKT offer were presented in a multidimensional heatmap. Results: Candidates receiving directed donor LDKT experienced the shortest wait times across all height and blood type categories, whereas end-chain LDKT recipients had the longest wait times. Non-White candidates were more likely to wait >2 years. Most White candidates received LDKT within 1-2 years. Candidates with blood type B had longer wait times. Conclusion: Blood type and the source of LDKT impacted wait times the most. Minorities waited longer for a LDKT, highlighting disparities in access to LDKT. Future studies should explore mechanisms driving these disparities.1. Baseline Characteristics - < 1 year (N=249) 1-2 years (N=197) > 2 years (N=213) p-value Recipient Age 49 (15) 47 (13) 52 (12) 0.002 Recipient Female Gender 84 (33.7%) 84 (42.6%) 88 (41.3%) 0.1 Type of Transplant < 0.001 Directed Donor LDKT 202 (81.1%) 123 (62.4%) 102 (47.9%) End Chain LDKT 7 (2.8%) 11 (5.6%) 39 (18.3%) Paired Kidney Exchange LDKT 40 (16.1%) 63 (32.0%) 72 (33.8%) Recipient Race < 0.001 White 159 (80.7%) 202 (81.1%) 136 (63.8%) Non-White 34 (15.6%) 51 (22.4%) 77 (36.2%)

Authors

Institutions

Publication Details

Journal
Journal of the American Society of Nephrology
Published
2025-10-01
DOI
https://doi.org/10.1681/asn.2025z0zhzffn
Primary Topic
Renal Transplantation Outcomes and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Factors Affecting Wait Times in Living-Donor Kidney Transplant

Divyash V. Shah, Srijan Tandukar, Pranav S. Kancherla, Sneha Chandrashekar et al.
Journal of the American Society of Nephrology
Renal Transplantation Outcomes and Treatments
article

Factors Affecting Wait Times in Living-Donor Kidney Transplant

Divyash V. Shah, Srijan Tandukar, Pranav S. Kancherla, Sneha Chandrashekar, Misha R Bankulla
article en

Abstract

Background: Living donor kidney transplant (LDKT) offers a life-saving option for patients with end stage kidney disease, reducing wait times compared to deceased donor transplants. However, the characteristics of candidates that wait a shorter period compared to those waiting longer is unclear. We stratified the cohort by duration of wait times for a LDKT to analyze characteristics. Methods: We included adult LDKT recipients at the University of Pennsylvania between 1/1/2015 and 11/30/2023. The wait time for a LDKT was defined as the time from the date of waitlisting to time of transplant. Patient characteristics were analyzed based on wait times of <1 year, 1-2 years, and >2 years. Pertinent factors determining wait times for a well-matched LDKT offer were presented in a multidimensional heatmap. Results: Candidates receiving directed donor LDKT experienced the shortest wait times across all height and blood type categories, whereas end-chain LDKT recipients had the longest wait times. Non-White candidates were more likely to wait >2 years. Most White candidates received LDKT within 1-2 years. Candidates with blood type B had longer wait times. Conclusion: Blood type and the source of LDKT impacted wait times the most. Minorities waited longer for a LDKT, highlighting disparities in access to LDKT. Future studies should explore mechanisms driving these disparities.1. Baseline Characteristics - < 1 year (N=249) 1-2 years (N=197) > 2 years (N=213) p-value Recipient Age 49 (15) 47 (13) 52 (12) 0.002 Recipient Female Gender 84 (33.7%) 84 (42.6%) 88 (41.3%) 0.1 Type of Transplant < 0.001 Directed Donor LDKT 202 (81.1%) 123 (62.4%) 102 (47.9%) End Chain LDKT 7 (2.8%) 11 (5.6%) 39 (18.3%) Paired Kidney Exchange LDKT 40 (16.1%) 63 (32.0%) 72 (33.8%) Recipient Race < 0.001 White 159 (80.7%) 202 (81.1%) 136 (63.8%) Non-White 34 (15.6%) 51 (22.4%) 77 (36.2%)

Journal of the American Society of NephrologyVol. 36(10S)
Hospital of the University of Pennsylvania (US)
Openalex Percentile: Top 43%
Renal Transplantation Outcomes and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.